Lamivudine for Chronic Hepatitis B

NCT00001457 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

NIH

Sponsor class

Conditions

Chronic Hepatitis B
Chronic Hepatitis D
Glomerulonephritis
Polyarteritis Nodosa

Interventions

DRUG: Lamivudine

Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)